# geneSignatures

## Scripts to calculate gene signatures which are indicator of treatment response, metastasis or microvascular invasion (MVI)

<en-note><div><br/></div><table WIDTH="1303px" STYLE="width:1303px;border-collapse:collapse;"><colgroup><col STYLE="width: 135px;"/><col STYLE="width: 185px;"/><col STYLE="width: 136px;"/><col STYLE="width: 150px;"/><col STYLE="width: 144px;"/><col STYLE="width: 328px;"/><col STYLE="width: 225px;"/></colgroup><tbody><tr><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Type</div></td><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Name of the signature</div></td><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Tool/Website</div></td><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Cancer Type</div></td><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Reference</div></td><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Remarks</div></td><td STYLE="background-color:rgb(254, 222, 193);color:#333;border-color:hsl(28.5, 96.8%, 70.1%);border-width:1px;border-style:solid;padding:10px;"><div>Code</div></td></tr><tr><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>TIDE</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>http://tide.dfci.harvard.edu/login/</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Melanoma</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(0, 0, 0);">PMID: </span><a HREF="https://www.ncbi.nlm.nih.gov/pubmed/30127393" REV="en_rl_none"><span STYLE="color:rgb(47, 74, 139);">30127393</span></a></div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Includes multiple signatures</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>no (web tool)</div></td></tr><tr><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>GEP</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Melanoma+pan-cancer</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(33, 33, 33);">PMID: </span><a HREF="https://pubmed.ncbi.nlm.nih.gov/28650338/" REV="en_rl_none">28650338</a></div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div><br/></div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>GEP.R</div></td></tr><tr><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>IMPRES</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Melanoma</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(0, 0, 0);">PMID: </span><a HREF="https://www.ncbi.nlm.nih.gov/pubmed/30127394" REV="en_rl_none"><span STYLE="color:rgb(47, 74, 139);">30127394</span></a></div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><ul><li><div>Gene list&nbsp; (pairs of genes)</div></li><li><div>Score is between 1 and 15</div></li><li><div>Reply showing that IMPRES is not reproducible: <span STYLE="color:rgb(33, 33, 33);">PMID: </span><a HREF="https://pubmed.ncbi.nlm.nih.gov/31806908/" REV="en_rl_none">31806908</a></div></li></ul></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>IMPRES.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Cytolytic score</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Pan-cancer</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(33, 33, 33);">PMID: </span><a HREF="https://www.cell.com/fulltext/S0092-8674(14)01639-0" REV="en_rl_none">25594174</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><i>GZMA</i> and <i>PRF1</i></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immune Class</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>HCC</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(33, 33, 33);">PMID: </span><a HREF="https://pubmed.ncbi.nlm.nih.gov/28624577/" REV="en_rl_none">28624577</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Gene list for HCC immune class (Sia et al. 2017)</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Inflammatory </div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>HCC</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>PMID: <a HREF="https://www.journal-of-hepatology.eu/article/S0168-8278(20)30479-7/fulltext" REV="en_rl_none">32710922</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>CD274 (PD-L1), CD8A, LAG3, STAT1</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>6-gene IFNG </div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Melanoma+pan-cancer</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(33, 33, 33);">PMID: </span><a HREF="https://pubmed.ncbi.nlm.nih.gov/28650338/" REV="en_rl_none">28650338</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>CXCL10, CXCL9, HLA-DRA, IDO1, IFNG, STAT1</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Gajewski_13_gene_inflammatory</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><br/></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>PMID: <a HREF="https://www.journal-of-hepatology.eu/article/S0168-8278(20)30479-7/fulltext" REV="en_rl_none">32710922</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>CCL2,&nbsp; &nbsp; CCL3,&nbsp; &nbsp; CCL4,&nbsp; &nbsp; CD8A,&nbsp; &nbsp; CXCL10,&nbsp; CXCL9,&nbsp;  GZMK,&nbsp; &nbsp; HLA-DMA HLA-DMB, HLA-DOA, HLA-DOB, ICOS,&nbsp; &nbsp; IRF1</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>antigen-presenting-cells</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><br/></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>PMID: <a HREF="https://www.journal-of-hepatology.eu/article/S0168-8278(20)30479-7/fulltext" REV="en_rl_none">32710922</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>CMKLR1,&nbsp; HLA-DQA1,&nbsp; HLA-DRB1, PSMB10</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Immunotherapy</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>Exhaused_T_Cell</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><br/></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>PMID: <a HREF="https://www.journal-of-hepatology.eu/article/S0168-8278(20)30479-7/fulltext" REV="en_rl_none">32710922</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>CD274, CD276, CD8A, LAG3, PDCD1LG2, TIGIT</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>MVI</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div> MVI 6-Gene</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>HCC</div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(80, 80, 80);">DOI: </span><a HREF="https://doi.org/10.1016/j.jhep.2021.09.034" REV="en_rl_none">https://doi.org/10.1016/j.jhep.2021.09.034</a></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div><i><span STYLE="color:rgb(80, 80, 80);">ROS1, UGT2B7, FAS, ANGPTL7, GMNN, MKI67</span></i></div></td><td STYLE="background-color:#f0d1f6;color:#333;border-color:hsl(290.29999999999995, 67.3%, 71.4%);border-width:1px;border-style:solid;padding:10px;"><div>GSVA_multiple_signatures.R</div></td></tr><tr><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>Metastasis</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div> Metastasis 6-Gene</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>-</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>HCC</div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(33, 33, 33);">PMID: </span><a HREF="https://clincancerres.aacrjournals.org/content/23/1/289.article-info" REV="en_rl_none">27449498</a></div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div><span STYLE="color:rgb(0, 0, 0);">MS = 0.51*</span><i><span STYLE="color:rgb(0, 0, 0);">AHCYL2</span></i><span STYLE="color:rgb(0, 0, 0);"> </span><b><span STYLE="color:rgb(0, 0, 0);">&ndash;</span></b><span STYLE="color:rgb(0, 0, 0);"> 0.54*</span><i><span STYLE="color:rgb(0, 0, 0);">LAMP2</span></i><span STYLE="color:rgb(0, 0, 0);"> </span><b><span STYLE="color:rgb(0, 0, 0);">&ndash;</span></b><span STYLE="color:rgb(0, 0, 0);"> 0.36*</span><i><span STYLE="color:rgb(0, 0, 0);">SPRY1</span></i><span STYLE="color:rgb(0, 0, 0);"> </span><b><span STYLE="color:rgb(0, 0, 0);">&ndash;</span></b><span STYLE="color:rgb(0, 0, 0);"> 0.33*</span><i><span STYLE="color:rgb(0, 0, 0);">SERPINA7</span></i><span STYLE="color:rgb(0, 0, 0);"> </span><b><span STYLE="color:rgb(0, 0, 0);">&ndash;</span></b><span STYLE="color:rgb(0, 0, 0);"> 0.33*</span><i><span STYLE="color:rgb(0, 0, 0);">FGGY</span></i><span STYLE="color:rgb(0, 0, 0);"> </span><b><span STYLE="color:rgb(0, 0, 0);">&ndash;</span></b><span STYLE="color:rgb(0, 0, 0);"> 0.18*</span><i><span STYLE="color:rgb(0, 0, 0);">ASLNC16648</span></i><span STYLE="color:rgb(0, 0, 0);"> + 0.001. (YBX1P4 for ASLN)</span></div></td><td STYLE="border-color:#ccc;border-width:1px;border-style:solid;padding:10px;"><div>not yet</div></td></tr></tbody></table><div><br/></div></en-note>      
